This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: Institut Pasteur, United States of America, as Represented by the Secretary of Agriculture, Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement. Active years: 2014-2025.
Company Filing History:
4 out of 897 
3 out of 1,215 
2 out of 49 
Years Active: 2014-2025
Title: Franck Biet: Innovator in Antigenic Tripeptides
Introduction
Franck Biet is a notable inventor based in Notre Dame d'Oe, France. He has made significant contributions to the field of biotechnology, particularly in the development of antigenic tripeptides. With a total of 4 patents to his name, Biet's work has implications for detecting infections in animals.
Latest Patents
One of Franck Biet's latest patents is focused on antigenic tripeptides derived from subsp. S-type strains. This invention involves an isolated synthetic tripeptide of the formula H-D-Phe-N-Methyl-L-Val-L-Ala-OMe (SEQ ID NO: 1), or a derivative thereof. The corresponding lipotripeptides are specific to the subsp. (Map) S-type strain, along with their derivatives and conjugates. The invention also addresses the use of these antigens in various methods and tests for detecting Map infection, particularly by assessing the humoral and cell-mediated responses of infected animals. Additionally, it includes a genetic signature of Map and signatures for its presence or infection through mass spectrometry and NMR spectroscopy.
Career Highlights
Throughout his career, Franck Biet has worked with prestigious organizations, including the Institut Pasteur and the United States of America, as represented by the Secretary of Agriculture. His innovative work has positioned him as a key figure in the field of infectious disease research.
Collaborations
Franck Biet has collaborated with notable colleagues such as Sylvie Bay and John P Bannantine. These partnerships have further enhanced his research and contributions to the scientific community.
Conclusion
Franck Biet's work in the development of antigenic tripeptides showcases his innovative spirit and dedication to advancing biotechnology. His patents and collaborations reflect his commitment to improving methods for detecting infections in animals.